CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 1 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,152,506 | -86.9% | 134,110 | -92.1% | 0.01% | -87.5% |
| Q1 2023 | $39,447,600 | +83.6% | 1,704,000 | +107.8% | 0.09% | +72.5% |
| Q4 2022 | $21,488,664 | +993.0% | 820,178 | +720.2% | 0.05% | +920.0% |
| Q3 2022 | $1,966,000 | -25.1% | 100,000 | -33.3% | 0.01% | -16.7% |
| Q2 2022 | $2,624,000 | – | 150,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |